Search Within

Amber Courtney King

Formats
  1. Meeting Abstract (14)
  2. Journal Article (11)
  3. Review (4)
  4. Research Letter (3)
Groups
  1. Adult Leukemia (27)
  2. Center for Hematologic Malignancies (27)
  3. Department of Medicine (27)
  4. Hematologic Malignancies, Division of (27)
  5. Weinberg Fellows (16)
  6. Biostatistics Service (9)

More Groups

People
  1. Jae Park (11)
  2. Martin Tallman (11)
  3. Mark Geyer (10)
  4. Andriy Derkach (7)
  5. Eytan Stein (7)
  6. Troy Horvat (7)

More People

Years
  1. 2023 (1)
  2. 2022 (5)
  3. 2021 (3)
  4. 2020 (5)
  5. 2019 (10)
  6. 2018 (3)

More Years

Publications
  1. Blood (14)
  2. Leukemia Research (4)
  3. Annals of Pharmacotherapy (3)
  4. Leukemia and Lymphoma (3)
  5. Blood Advances (2)
  6. Journal of the Advanced Practitioner in Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Elsevier Ltd (4)
  3. Sage Publications (3)
  4. Taylor & Francis Group (3)
  5. Harborside Press (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Research Letter

    Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Meeting Abstract

    Parisi, R.; Cowen, E. A.; Gu, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Blood (2022)

    Fulltext@MSK | Save
  • Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis
    Research Letter

    King, A. C.; Derkach, A.; Weis, T. M.; Stump, S. E.; Ciervo, J. R.; Ranaghan, C. P.; Stein, E. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Real-world management of targeted therapies in chronic lymphocytic leukemia
    Review

    Weis, T. M.; Gutierrez, J.; Kabel, C. C.; King, A. C.; Daley, R. J.; Stump, S. E.
    Journal of Oncology Pharmacy Practice (2022)

    Fulltext@MSK | Save
  • Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
    Journal Article

    Wudhikarn, K.; King, A. C.; Geyer, M. B.; Roshal, M.; Bernal, Y.; Gyurkocza, B.; Perales, M. A.; Park, J. H.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
    Research Letter

    King, A. C.; Weis, T. M.; Derkach, A.; Ball, S.; Pandey, M.; Mauro, M. J.; Goldberg, A. D.; Stahl, M.; Famulare, C.; Tallman, M. S.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
    Journal Article

    Glass, J. L.; Derkach, A.; Hilden, P.; King, A.; Seo, S. K.; Ahr, K.; Kishtagari, A.; Levine, R. L.; Tallman, M. S.; Douer, D.
    Leukemia Research (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save